BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38609343)

  • 1. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
    Filaferro L; Zaccarelli F; Niccolini GF; Colizza A; Zoccali F; Grasso M; Fusconi M
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):435-445. PubMed ID: 38609343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of statins: A focus on cancer.
    Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and cancer: current and future prospects.
    Osmak M
    Cancer Lett; 2012 Nov; 324(1):1-12. PubMed ID: 22542807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The statins as anticancer agents.
    Chan KK; Oza AM; Siu LL
    Clin Cancer Res; 2003 Jan; 9(1):10-9. PubMed ID: 12538446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins: a repurposed drug to fight cancer.
    Jiang W; Hu JW; He XR; Jin WL; He XY
    J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and Colorectal Cancer - A Systematic Review.
    Dobrzycka M; Spychalski P; Łachiński AJ; Kobiela P; Jędrusik P; Kobiela J
    Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):255-262. PubMed ID: 30149418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of statins in cancer prevention and treatment.
    Stamm JA; Ornstein DL
    Oncology (Williston Park); 2005 May; 19(6):739-50; discussion 753-4. PubMed ID: 15971450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological actions of statins: a critical appraisal in the management of cancer.
    Gazzerro P; Proto MC; Gangemi G; Malfitano AM; Ciaglia E; Pisanti S; Santoro A; Laezza C; Bifulco M
    Pharmacol Rev; 2012 Jan; 64(1):102-46. PubMed ID: 22106090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins, stem cells, and cancer.
    Gauthaman K; Fong CY; Bongso A
    J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.
    Lopez-Pedrera C; Ruiz-Limon P; Valverde-Estepa A; Barbarroja N; Rodriguez-Ariza A
    Curr Drug Targets; 2012 Jun; 13(6):829-41. PubMed ID: 22250652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anticancer properties of statins].
    Sławińska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of statins use on risk and prognosis of breast cancer: a meta-analysis.
    Zhao G; Ji Y; Ye Q; Ye X; Wo G; Chen X; Shao X; Tang J
    Anticancer Drugs; 2022 Jan; 33(1):e507-e518. PubMed ID: 34407042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The statins: multifunctional antithrombotic and antineoplastic drugs.
    Splichal JE; Stamm JA; Ornstein DL
    Semin Thromb Hemost; 2003 Jun; 29(3):259-74. PubMed ID: 12888930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies.
    Gizzo S; Quaranta M; Nardelli GB; Noventa M
    Curr Drug Targets; 2015; 16(10):1142-59. PubMed ID: 25901529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.